Introduction
Supplement safety is often discussed in very general terms, but in practice the risks depend heavily on the individual. A supplement that is reasonable for one person may be inappropriate for another based on their medications, health conditions, dose, formulation, or the other products they are already using.
This becomes especially important when supplements interact with medications or underlying medical conditions. Some interactions can change how a drug is absorbed, metabolised, transported, or cleared from the body. Others can amplify or oppose the drug’s clinical effect, such as increasing sedation, lowering blood pressure or blood glucose, or affecting bleeding risk.
In this episode, Giulia Guerrini, a GPhC-registered pharmacist and researcher at Examine, talks about how clinicians and practitioners can think more systematically about supplement safety, side effects, contraindications, and drug–supplement interactions.
- [02:39] Interview start
- [05:21] Why context matters
- [06:38] Timing and formulation
- [12:58] Rating interaction risk
- [22:39] Berberine benefits and interactions
- [27:33] Adaptogens quality concerns
- [30:15] Melatonin safety questions
- [36:30] Stacking supplements risks
- [41:50] Quality control and regulation
- [55:35] Key ideas segment (premium-only)
Episode Resources
- Free trial of Examine Clinician Edition – For health & nutrition professionals. Includes the Supplement Navigator (safety and interaction checking), plus all other Examine tools (study summaries, supplement database, in-depth guides, etc.)
- Free trial of Examine+ – For anyone wanting to make evidence-based decisions about supplements and health. Includes: 100+ study summaries a month. The full supplement database. In-depth guides. ExamineAI. Doesn’t include the Supplement Navigator.
- Subscribe to Sigma Nutrition Premium
Guest Information
Giulia Guerrini, MPharm, is a registered pharmacist with a master’s degree in chemistry and pharmaceutical technology from the University of Ferrara in Italy. She worked in various pharmacies throughout London as a locum pharmacist before joining an online pharmacy tech startup as pharmacy director.
She currently works at Examine as a researcher, where a large part of her role is to increase awareness about the correct and safe use of supplements, especially when potentially interacting with other medications.
Study Notes
Useful Terminology
- Supplement Safety: Safety is not an intrinsic yes-or-no property of an ingredient; it depends on dose, formulation, route of administration, timing, user characteristics, coexisting medical conditions, medication use, and product quality.
- Drug–Supplement Interaction: A situation in which a supplement changes the effect, concentration, absorption, metabolism, or safety profile of a medication, or vice versa. Interactions may be clinically trivial, moderate, or severe depending on the medication involved and the potential consequences.
- Pharmacokinetic Interaction: An interaction that affects what the body does to a medication or supplement, including absorption, distribution, metabolism, or elimination. Examples include supplements that inhibit cytochrome P450 enzymes, thereby increasing drug concentrations, or induce enzymes, thereby reducing drug exposure.
- Pharmacodynamic Interaction: An interaction in which a supplement and medication have overlapping or opposing physiological effects, even without changing blood concentrations. Examples include additive sedative effects, blood pressure-lowering effects, anticoagulant effects, or glucose-lowering effects.
- Cytochrome P450 Enzymes: A large family of enzymes involved in the metabolism of many medications.
- Therapeutic Window: The range between an effective dose and a toxic or ineffective dose of a medication.
- Bioavailability: The proportion of an active ingredient that is absorbed and becomes available to exert a biological effect.
- Modified-Release Formulation: A formulation designed to release an active ingredient gradually rather than immediately. This may improve convenience or tolerability in some cases, but it can also change absorption, dose exposure, or therapeutic usefulness compared with immediate-release forms.
- Adulteration: The intentional or accidental presence of undeclared ingredients in a supplement, such as pharmaceuticals, stimulants, anabolic steroids, or cheaper substitute plant species.
- Proprietary Blend: A supplement formulation that lists multiple ingredients together without clearly disclosing the exact dose of each ingredient.
Safety Is Context-Dependent, Not Ingredient-Dependent Alone
Asking whether a supplement is “safe” is incomplete unless the context is defined. A supplement may be low risk for one person, ineffective or poorly absorbed for another, and dangerous for someone else taking a medication or living with a particular medical condition. This makes supplement safety closer to clinical risk assessment than simple ingredient classification.
- Safety depends on the person using the supplement.
- Medical conditions can substantially alter risk.
- For example, calcium supplementation may be generally well tolerated in many people but can be problematic in people with chronic kidney disease, osteoporosis requiring high-dose calcium and vitamin D, certain cancers, or other conditions associated with hypercalcaemia risk.
- Pregnancy, lactation, childhood, older age, and chronic disease can change metabolism, nutrient handling, drug clearance, and vulnerability to adverse effects.
- A supplement that appears low risk in a healthy adult cannot automatically be assumed to have the same safety profile in children, pregnant women, older adults, or people with organ dysfunction.
- Medical conditions can substantially alter risk.
- Safety depends on timing.
- Melatonin illustrates how timing can transform an intended effect into an adverse effect. Taken before bed, sedation may be desired; taken in the morning, drowsiness or dizziness may become problematic.
- Timing relative to food, medications, and other supplements can also affect absorption. Iron is a key example because its absorption can be reduced by calcium, grains, seeds, non-